Request Reader Training
Cerianna (fluoroestradiol F 18) injection is an estrogen-receptor targeted radiotracer (e-RTR) prescribed to detect whole-body ER+ lesions in recurrent or metastatic breast cancer patients that may inform clinical decisions.
GE Healthcare has designed peer-to-peer reader training programs in a variety of formats to help you accurately interpret Cerianna images.
We offer convenient virtual training to fit your learning style and schedule.
Register using the form below to request a training session. You will be contacted by our training team within 48 hours.
500 W. Monroe Street | Chicago, IL 60661
© 2022 General Electric Company
GE and the GE Monogram are trademarks of the General Electric Company.